Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer
=================================================================================================================================

* Mohamed A Ghonim
* Salome V Ibba
* Abdelmetalab F Tarhuni
* Youssef Errami
* Hanh H Luu
* Matthew J Dean
* Ali H El-Bahrawy
* Dorota Wyczechowska
* Ilyes A Benslimane
* Luis Del Valle
* Amir A Al-Khami
* Augusto C Ochoa
* A Hamid Boulares